Daxor Corporation (NASDAQ: DXR)
$9.02
-0.1800 ( -1.96% ) 0.2K
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
Market Data
Open
$9.02
Previous close
$9.20
Volume
0.2K
Market cap
$44.50M
Day range
$8.91 - $9.31
52 week range
$7.11 - $10.15
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
nt-ncsr/a | Quarterly Reports | 1 | Feb 29, 2024 |
nt-ncsr | Quarterly Reports | 1 | Feb 29, 2024 |
8-k | 8K-related | 14 | Jan 02, 2024 |
4 | Insider transactions | 1 | Dec 06, 2023 |
4 | Insider transactions | 1 | Dec 01, 2023 |
4 | Insider transactions | 1 | Dec 01, 2023 |
8-k | 8K-related | 13 | Nov 28, 2023 |
4 | Insider transactions | 1 | Nov 27, 2023 |
4 | Insider transactions | 1 | Nov 24, 2023 |
nport-p | Other | 1 | Nov 24, 2023 |